We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Varian Acquires IonSpec

By Biotechdaily staff writers
Posted on 10 Mar 2006
Varian, Inc. More...
(Palo Alto, CA, USA) has acquired IonSpec Corp. (Lake Forest, CA, USA) for approximately U.S.$16 million.

Varian said the acquisitions of IonSpec's Fourier transform mass spectrometry (FTMS) technology represents a significant step toward expanding its information-rich detection (IRD) portfolio.

Varian expects the acquisition to increase its development of growing life science applications, specifically the study of proteins, nucleic acids, and drug metabolites. The initial cash purchase price includes paying down assumed debt and an opportunity for an additional payment if FTMS products reach specified financial targets over a three-year period.

FTMS instruments are used in laboratories worldwide to determine the function and structural characterization of proteins and other biomolecules in various biologic systems.




Related Links:
Varian
IonSpec

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Hematology Consumables
Bioblood Devices
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.